全文获取类型
收费全文 | 15252篇 |
免费 | 1142篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 206篇 |
儿科学 | 260篇 |
妇产科学 | 213篇 |
基础医学 | 2289篇 |
口腔科学 | 160篇 |
临床医学 | 1546篇 |
内科学 | 3664篇 |
皮肤病学 | 395篇 |
神经病学 | 1522篇 |
特种医学 | 668篇 |
外国民族医学 | 11篇 |
外科学 | 2374篇 |
综合类 | 44篇 |
一般理论 | 5篇 |
预防医学 | 718篇 |
眼科学 | 200篇 |
药学 | 1017篇 |
中国医学 | 15篇 |
肿瘤学 | 1154篇 |
出版年
2023年 | 150篇 |
2022年 | 236篇 |
2021年 | 648篇 |
2020年 | 349篇 |
2019年 | 541篇 |
2018年 | 656篇 |
2017年 | 420篇 |
2016年 | 482篇 |
2015年 | 552篇 |
2014年 | 735篇 |
2013年 | 886篇 |
2012年 | 1334篇 |
2011年 | 1306篇 |
2010年 | 710篇 |
2009年 | 644篇 |
2008年 | 987篇 |
2007年 | 961篇 |
2006年 | 832篇 |
2005年 | 774篇 |
2004年 | 662篇 |
2003年 | 561篇 |
2002年 | 494篇 |
2001年 | 129篇 |
2000年 | 126篇 |
1999年 | 110篇 |
1998年 | 94篇 |
1997年 | 63篇 |
1996年 | 65篇 |
1995年 | 60篇 |
1994年 | 49篇 |
1993年 | 41篇 |
1992年 | 71篇 |
1991年 | 72篇 |
1990年 | 67篇 |
1989年 | 60篇 |
1988年 | 50篇 |
1987年 | 45篇 |
1986年 | 41篇 |
1985年 | 32篇 |
1984年 | 37篇 |
1983年 | 33篇 |
1982年 | 41篇 |
1981年 | 20篇 |
1980年 | 17篇 |
1979年 | 20篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1974年 | 24篇 |
1973年 | 15篇 |
1972年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
41.
42.
J L Guéant L Kamel D A Moneret-Vautrin S Widmer M C Laxenaire J P Nicolas 《Annales fran?aises d'anesthèsie et de rèanimation》1986,5(6):570-573
A radio-immunoassay (RIA) was used to screen for specific IgE to myorelaxants. Alcuronium was coupled to epoxy-activated Sepharose. Sixteen patients with anaphylaxis to alcuronium (n = 2), gallamine (n = 2) or suxamethonium (n = 12) were studied. The diagnosis was established by intradermal tests (ID), passive cutaneous anaphylaxis tests and human basophil degranulation tests. The amount of non specific label retained by Sepharose-ethanolamine (with sera of patients) and Sepharose-alcuronium (with sera of 11 control subjects) was estimated. The RIA was positive 10/16 (8/14 patients having reacted to a muscle relaxant other than alcuronium). The RIA seemed to be useful in the diagnosis of anaphylaxis to muscle relaxants. Drug-reactive antibodies were specific of the quaternary ammonium radical, which was the common allergenic determinant of all molecules of muscle relaxants. This test accounted for in vitro cross-reactivity, but had no predictive value for the clinical risk of crossed-anaphylaxis. This risk was best assessed by ID; it was positive in three cases. Although it was not possible to compare ID and RIA, the interpretation of which was different, both tests should be recommended for the detection of sensitivity to muscle relaxants. 相似文献
43.
Muriel Wisniewski Alain Le Borgne Nicolas Spassky 《Macromolecular chemistry and physics.》1997,198(4):1227-1238
The polymerization of lactides with various D /L enantiomeric compositions using achiral Schiff's base/aluminium methoxide as initiator (SALENAlOCH3) in dichloromethane solution at 70°C is reported. The conversion was kept below 70% in order to limit transesterification reactions. The polymers obtained after precipitation show a narrow molecular weight distribution (ratio of weight- to number-average molecular weights M w/M n = 1,1–1,2) and an optical rotation higher than that expected from the optical purity of the starting monomers. The examination of the thermal properties reveals that whatever their enantiomeric composition all the prepared polymers are crystalline. This unusual behavior is explained by an end-chain propagation mechanism producing stereocopolymers with long enantiomeric sequences, i.e., increased isotacticity as substantiated by an examination of the microstructure of the polymers by means of 13C nuclear magnetic resonance. A stereocomplex formation was observed for stereocopolymers with optical purities below 40%. 相似文献
44.
45.
46.
In human cortex and hippocampus area, [3H]5-HT (5 nM) labels 5-HT1A, 5-HT1D and 5-HT1E sites. After masking 5-HT1A receptors by 0.1 μM 8-OH-DPAT, the binding displaced by 0.1 μM 5-CT presumably represented 5-HT1D sites and the remaining binding 5-HT1E sites. In frontal cortex, 5-HT1A receptors represented the main binding in layers II and VI and a lower fraction on other layers. 5-HT1D and 5-HT1E sites, were more homogeneously distributed in layers II to VI (21–34% of specific [3H]5-HT binding). 5-HT1E sites were of similar affinities (KD close to 6–8 nM) in the cortical layers II to VI. In CA1 field of hippocampus, (pyramidal layer, stratum radiatum, molecular layer), CA2 and dentate gyrus, 5-HT1A receptors represented the major fraction, 5-HT1D sites a significant fraction and 5-HT1E a minor fraction of the specific [3H]5-HT binding. In CA3–CA4 fields, 5-HT1A receptors were less densely present, 5-HT1D sites were predominant and 5-HT1E sites represented a significant fraction (27%). The highest densities of 5-HT1E sites have been measured in subiculum, where 5-HT1A, 5-HT1D, and 5-HT1E binding sites were equally represented and in entorhinal cortex where 5-HT1E sites represented the major binding in layer III. They were also present in layers II and IV (29 and 24%) and, to a lesser extent, in layers V and VI. 5-HT1A sites were predominant in layer VI, II and V and were less abundant in other layers. 5-HT1D were homogeneously present in layers II, III, IV and were present in low amounts in other layers. No 5-HT1E were detected in choroid plexus, where [3H]5-HT was dramatically reduced by mesulergine (5-HT2C receptors). No significant displacement of [3H]5-HT by mesulergine was measured in other structures. 相似文献
47.
48.
M L D'Amour L H Lebrun A Rabbat J Trudel N Daneault 《The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques》1987,14(2):127-130
Six patients with an aortoiliac vascular disease and a peripheral neurological deficit are presented. Clinical and electromyographic findings revealed lumbosacral plexus, sciatic and femoral nerve lesions. A correlation is made between the level of the vascular lesion (aortic, aortoiliac or distally) and the type of peripheral nerve deficit observed. In a patient complaining of pain, weakness, or numbness in a leg, the differential diagnosis should include aortoiliac vascular disease. The peripheral neurological symptoms may be the initial manifestation of the vascular disease or may appear in the early post-operative period. 相似文献
49.
Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. 总被引:13,自引:0,他引:13
Marc Levivier Nicolas Massager David Wikler José Lorenzoni Salvador Ruiz Daniel Devriendt Philippe David Fran?oise Desmedt Stéphane Simon Paul Van Houtte Jacques Brotchi Serge Goldman 《Journal of nuclear medicine》2004,45(7):1146-1154
We developed a technique that allows the routine integration of PET in stereotactic neurosurgery, including radiosurgery. We report our clinical experience with the combined use of metabolic (i.e., PET) and anatomic (i.e., MRI and CT) images for the radiosurgical treatment of brain tumors. We propose a classification describing the relative role of the information provided by PET in this multimodality image-guided approach. METHODS: Between December 1999 and March 2003, 57 patients had stereotactic PET as part of their image acquisition for the planning of gamma knife radiosurgery. Together with stereotactic MRI and CT, stereotactic PET images were acquired on the same day using either (18)F-FDG or (11)C-methionine. PET images were imported in the planning software for the radiosurgery dosimetry, and the target volume was defined using the combined information of PET and MRI or CT. To analyze the specific contribution of the PET findings, we propose a classification that reflects the strategy used to define the target volume. RESULTS: The patients were offered radiosurgery with PET guidance when their tumor was ill-defined and we anticipated some limitation of target definition on MRI alone. This represents 10% of the radiosurgery procedures performed in our center during the same period of time. There were 40 primary brain lesions, 7 metastases, and 10 pituitary adenomas. Abnormal PET uptake was found in 62 of 72 targets (86%), and this information altered significantly the MRI-defined tumor in 43 targets (69%). CONCLUSION: The integration of PET in radiosurgery provides additional information that opens new perspectives for the optimization of the treatment of brain tumors. 相似文献
50.
Orlando Parise Franois Janot Bernard Luboinski Liliane Massaad Nicolas Albin Caroline Toussaint Marie-Ange Verjus Marc Bonnay Alain Gouyette Guy G. Chabot 《Head & neck》1994,16(2):158-164
Background. Head and neck squamous cell carcinomas (HNSCC) present variable aggressiveness and chemosensitivity. Because the glutathione (GSH) system and thymidylate synthase (TS) are involved in the resistance to the main drugs used in HNSCC (cisplatin and 5-FU), we studied these systems in tumors and normal mucosae. Methods. Tumor samples and normal adjacent mucosae were collected from 37 untreated HNSCC patients. GSH and glutathione S-transferase (GST) activity were assayed by spectrophotometry, whereas TS activity and folates were determined by radioassays. Results. Mean GSH levels were higher in tumors (15.2 ± 8.2 nmol/mg protein) than in mucosae (8.3 ± 4.1 nmol/mg protein) (p = 0.005, paired t test). GST activity was also higher in tumors (394 ± 194 nmol/min/mg protein) than in mucosae (261 ± 132 nmol/min/mg protein) (p = 0.0003). TS activity was markedly higher in tumors (9.2 ± 21.5 pmol/min/mg protein) compared to that of mucosae (0.9 ± 1.2 pmol/min/mg protein) (p = 0.0001). Folate levels in tumors and mucosae were similar (1.2 ± 1.1 and 0.8 ± 0.9 pmol/mg protein, respectively; p = 0.1, NS). In relation to clinical stage and tumor size, a statistical difference was found in GSH and GST values between tumors and mucosae for stage IV and T3/T4. The increase in tumor TS compared to that of mucosae was significant for all clinical stages, tumor sizes, and nodal involvement. Conclusions. These data enhance our understanding of the enzymatic systems involved in cisplatin and 5-fluorouracil (5-FU) resistance in HNSCC and normal mucosae and may help to elucidate tumor behavior and interpatient differences in drug sensitivity. © 1994 John Wiley & Sons, Inc. 相似文献